Veradermics

Hair loss biotech Veradermics files for a $100 million IPO February 4, 2026 News Hair loss biotech Veradermics prices upsized IPO at $17, above the range Veradermics, a Phase 3-ready biotech developing therapies for hair loss, raised $256 million by... Read more